Textron Investing Cash Flow increased by 35.8% to -$104.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 10300.0%, from -$1.00M to -$104.00M. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows an upward trend with a -7.4% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.00M | -$70.00M | -$62.00M | -$154.00M | $28.00M | -$232.00M | -$80.00M | -$163.00M | -$29.00M | -$57.00M | -$68.00M | -$163.00M | -$63.00M | -$48.00M | -$78.00M | -$95.00M | -$1.00M | $18.00M | -$62.00M | -$162.00M | -$104.00M |
| QoQ Change | — | <-999% | +11.4% | -148.4% | +118.2% | -928.6% | +65.5% | -103.8% | +82.2% | -96.6% | -19.3% | -139.7% | +61.3% | +23.8% | -62.5% | -21.8% | +98.9% | >999% | -444.4% | -161.3% | +35.8% |
| YoY Change | — | — | — | — | +460.0% | -231.4% | -29.0% | -5.8% | -203.6% | +75.4% | +15.0% | +0.0% | -117.2% | +15.8% | -14.7% | +41.7% | +98.4% | +137.5% | +20.5% | -70.5% | <-999% |